Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
Status:
Terminated
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The study will enroll 30 opioid-dependent participants into an open-label pilot outpatient
study of methods to facilitate induction and stabilization onto XR-NTX. There will be three
different methods of XR-NTX induction using increasing doses of oral naltrexone and
buprenophine.